ZBTB7A functioned as an oncogene in colorectal cancer

Background: Despite zinc finger and BTB domain-containing 7A (ZBTB7A) documented importance in multiple tumors, the function and clinical value in Colorectal cancer (CRC) remain elusive. The aim of this study was to evaluate the functional roles and the clinical value of ZBTB7A in CRC progression. M...

Full description

Saved in:
Bibliographic Details
Published inBMC Gastroenterology
Main Authors Wang, Li, Meng-Xia, Zhang, Mei-Fang, Zhang, Zi-Wei Tu
Format Web Resource
LanguageEnglish
Published Durham Research Square 16.09.2020
Subjects
Colorectal cancer
Medical prognosis
Online AccessGet full text

Cover

More Information
Summary:Background: Despite zinc finger and BTB domain-containing 7A (ZBTB7A) documented importance in multiple tumors, the function and clinical value in Colorectal cancer (CRC) remain elusive. The aim of this study was to evaluate the functional roles and the clinical value of ZBTB7A in CRC progression. Methods: The level of ZBTB7A was detected in a large cohort of CRC patients (n=189) by immunohistochemistry (IHC), and we analyzed the diagnostic and prognostic value of the protein. In addition, the functional roles of ZBTB7A on CRC were explored in vitro and in vivo. Results: Survival analyses indicated that patients with high ZBTB7A expression made the prognosis worse (P=0.024). Functionally, knockdown of ZBTB7A could markedly inhibit tumor proliferation in vitro and in vivo, whereas ZBTB7A overexpression displayed the opposite results. Conclusions: ZBTB7A was associated with poor survival outcomes and functioned as an oncogene in CRC patients, indicating that it is a potential prognostic biomarker and therapeutic target for CRC patients.
DOI:10.21203/rs.3.rs-48830/v2